ACTRN12620000984998: Cancer Molecular Screening and Therapeutics (MoST) Program Substudy Addendum 11 substudy 25-26: Tildrakizumab |
|
|
| Active, not recruiting | 2 | 32 | | | The University of Sydney, Office for Health and Medical Research, Australian Genomic Cancer Medicine Centre (AGCMC) | Cancer, Advanced Osteosarcoma , Soft Tissue Sarcoma | | | | |
